The Union Health Ministry of India has approved Corbevax as a heterologous COVID-19 booster dose under emergency use authorization for individuals aged 18 years.
The Central Power Research Institute (CPRI) has signed an MoU with the Chhattisgarh govt for setting up a regional testing laboratory in the Raipur district.